Sonpavde G - Search Results

1

Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.

Hilton WM, Ercole B, Parekh DJ, Sonpavde G, Ghosh R, Svatek RS. Hilton WM, et al. Among authors: sonpavde g. Expert Rev Anticancer Ther. 2011 Jun;11(6):949-57. doi: 10.1586/era.11.69. Expert Rev Anticancer Ther. 2011. PMID: 21707292 Review.

2

Perioperative chemotherapy for bladder cancer.

Sonpavde G, Petrylak DP. Sonpavde G, et al. Crit Rev Oncol Hematol. 2006 Feb;57(2):133-44. doi: 10.1016/j.critrevonc.2005.05.004. Epub 2005 Jun 28. Crit Rev Oncol Hematol. 2006. PMID: 15990329 Review.

3

Current optimal chemotherapy for advanced urothelial cancer.

Sonpavde G, Galsky MD, Hutson TE. Sonpavde G, et al. Expert Rev Anticancer Ther. 2008 Jan;8(1):51-61. doi: 10.1586/14737140.8.1.51. Expert Rev Anticancer Ther. 2008. PMID: 18095883 Review.

4

Neoadjuvant chemotherapy preceding cystectomy for bladder cancer.

Sonpavde G, Amiel GE, Mims MP, Hayes TG, Lerner SP. Sonpavde G, et al. Expert Opin Pharmacother. 2008 Aug;9(11):1885-93. doi: 10.1517/14656566.9.11.1885. Expert Opin Pharmacother. 2008. PMID: 18627327 Review.

5

Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome.

Tilki D, Reich O, Karakiewicz PI, Novara G, Kassouf W, Ergün S, Fradet Y, Ficarra V, Sonpavde G, Stief CG, Skinner E, Svatek RS, Lotan Y, Sagalowsky AI, Shariat SF. Tilki D, et al. Among authors: sonpavde g. Eur Urol. 2010 Jul;58(1):112-7. doi: 10.1016/j.eururo.2010.01.015. Epub 2010 Jan 20. Eur Urol. 2010. PMID: 20097469

6

Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials.

Sonpavde G, Palapattu GS. Sonpavde G, et al. Expert Rev Anticancer Ther. 2010 Mar;10(3):439-50. doi: 10.1586/era.10.17. Expert Rev Anticancer Ther. 2010. PMID: 20214524 Review.

7

pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.

Tilki D, Svatek RS, Karakiewicz PI, Novara G, Seitz M, Sonpavde G, Gupta A, Kassouf W, Fradet Y, Ficarra V, Skinner E, Lotan Y, Sagalowsky AI, Stief CG, Reich O, Shariat SF. Tilki D, et al. Among authors: sonpavde g. J Urol. 2010 Aug;184(2):470-4. doi: 10.1016/j.juro.2010.04.007. Epub 2010 Jun 17. J Urol. 2010. PMID: 20620401

8

Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.

Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O, Shariat SF. Tilki D, et al. Among authors: sonpavde g. J Urol. 2010 Sep;184(3):888-94. doi: 10.1016/j.juro.2010.04.081. J Urol. 2010. PMID: 20643448

9

Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.

Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF. Sonpavde G, et al. BJU Int. 2011 Sep;108(5):687-92. doi: 10.1111/j.1464-410X.2010.09902.x. Epub 2010 Nov 19. BJU Int. 2011. PMID: 21087453

10

Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.

Sonpavde G, Khan MM, Lerner SP, Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D, Kassouf W, Fradet Y, Dinney CP, Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M, Sagalowsky AI, Lotan Y, Shariat SF. Sonpavde G, et al. J Urol. 2011 Feb;185(2):456-61. doi: 10.1016/j.juro.2010.09.110. Epub 2010 Dec 17. J Urol. 2011. PMID: 21167527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

489 results

Search Page